Zhao N, Chopra S, Trepka K, Wang YH, et al. CUB domain containing protein 1 (CDCP1) is a target for radioligand therapy in castration resistant prostate cancer including PSMA null disease. Clin Cancer Res 2022 May 23. pii: 699115. doi: 10.1158/1078-0432.CCR-21-3858.
PMID: 35604681